Advertisement

Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study

Florent Joly, Camille Cohen, Vincent Javaugue, Sébastien Bender, Mohamed Belmouaz, Bertrand Arnulf, Bertrand Knebelmann, Mathilde Nouvier, Vincent Audard, François Provot, Viviane Gnemmi, Dominique Nochy, Jean Michel Goujon, Arnaud Jaccard, Guy Touchard, Jean Paul Fermand, Christophe Sirac and Frank Bridoux

Article Information

PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted September 18, 2018
  • Accepted December 15, 2018
  • Published online December 21, 2018.

Article Versions


Contributors 
  • Florent Joly, 1 Department of Nephrology, CHU Poitiers, Centre National de Reference Maladies Rares, Amylose AL et Autres Maladies a Depots d'Immunoglobulines Monoclonales, Poitiers, France;
  • Camille Cohen, 2 Department of Nephrology, Necker hospital, Paris, France;
  • Vincent Javaugue, 1 Department of Nephrology, CHU Poitiers, Centre National de Reference Maladies Rares, Amylose AL et Autres Maladies a Depots d'Immunoglobulines Monoclonales, Poitiers, France;
  • Sébastien Bender, 3 CNRS UMR 7276-CRIBL, University of Limoges; and French National Reference Centre, AL Amyloidosis & Other Monoclonal Immunoglobulin Deposition Diseases, University Hospital Dupuytren, Limoges, France;
  • Mohamed Belmouaz, 1 Department of Nephrology, CHU Poitiers, Centre National de Reference Maladies Rares, Amylose AL et Autres Maladies a Depots d'Immunoglobulines Monoclonales, Poitiers, France;
  • Bertrand Arnulf, 4 Department of Immunology and Hematology, Saint Louis Hospital, Paris, France;
  • Bertrand Knebelmann, 5 INSERM U1151 mechanisms and therapeutic strategies of chronic kidney diseases, Necker hospital, Paris, France;
  • Mathilde Nouvier, 6 Department of Nephrology, Lyon Sud Hospital, Lyon, France;
  • Vincent Audard, 7 Department of Nephrology, Assistance Publique des Hopitaux de Paris (AP-HP), Groupe Hospitalier Henri-Mondor/ Albert Chenevier, Creteil, France;
  • François Provot, 8 Department of Nephrology, CHRU, Lille, France;
  • Viviane Gnemmi, 9 Department of Pathology, CHRU, Lille, France;
  • Dominique Nochy, 10 Department of Pathology, HEGP, Paris, France;
  • Jean Michel Goujon, 11 Department of Pathology CHU Poitiers, Centre National de Reference Maladies Rares, Amylose AL et Autres Maladies a Depots d'Immunoglobulines Monoclonales, Poitiers, France;
  • Arnaud Jaccard, 12 Department of Hematology, CHU Limoges, Centre National de Reference Maladies Rares, Amylose AL et Autres Maladies a Depots d'Immunoglobulines Monoclonales, Limoges, France
  • Guy Touchard, 1 Department of Nephrology, CHU Poitiers, Centre National de Reference Maladies Rares, Amylose AL et Autres Maladies a Depots d'Immunoglobulines Monoclonales, Poitiers, France;
  • Jean Paul Fermand, 4 Department of Immunology and Hematology, Saint Louis Hospital, Paris, France;
  • Christophe Sirac, 3 CNRS UMR 7276-CRIBL, University of Limoges; and French National Reference Centre, AL Amyloidosis & Other Monoclonal Immunoglobulin Deposition Diseases, University Hospital Dupuytren, Limoges, France;
  • Frank Bridoux, 1 Department of Nephrology, CHU Poitiers, Centre National de Reference Maladies Rares, Amylose AL et Autres Maladies a Depots d'Immunoglobulines Monoclonales, Poitiers, France;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output